Viridian Therapeutics, Inc.\DE (VRDN) › Net IncomeViridian Therapeutics, Inc.\DE (VRDN) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$2.16M2014: -$7.89M2015: -$11.33M2016: -$17.27M2017: -$26.51M2018: -$32.70M2019: -$41.87M2020: -$110.72M2021: -$79.41M2022: -$129.87M2023: -$237.73M2024: -$269.95M2025: -$342.60M-$342.60M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$342.60M-26.9%2024-$269.95M-13.6%2023-$237.73M-83.0%2022-$129.87M-63.5%2021-$79.41M+28.3%2020-$110.72M-164.4%2019-$41.87M-28.0%2018-$32.70M-23.4%2017-$26.51M-53.5%2016-$17.27M-52.5%2015-$11.33M-43.6%2014-$7.89M-265.3%2013-$2.16M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share